Received: 22 March 2020
Accepted: 3 August 2020
First Online: 10 August 2020
Ethics approval and consent to participate
: Obtained by Agence Nationale de Sécurité du Médicament (July 2th, 2019), and ethics committee “Comité de Protection des Personnes” (July 18th, 2019). Reference ethical committee 19 05 47, reference CNRIPH 19.05.07.54754. Number EUDRACT 2018–002971-17. Consent to participate was written.
: Not applicable.
: The funding bodies played a role in the design of the study and in writing the manuscript but played no role in collection, analysis, and interpretation of data.